Recently stock market analysts have updated their consensus ratings on shares of Lifevantage Corporation (LFVN).
Most recent broker ratings
09/08/2014 – Midtown Partners began new coverage on Lifevantage Corporation giving the company a “buy” rating. They now have a USD 1.43 price target on the stock.
Lifevantage Corporation has a 50 day moving average of 10.48 and a 200 day moving average of 11.96. The stock’s market capitalization is 127.33M, it has a 52-week low of 4.87 and a 52-week high of 15.97.
The share price of the company (LFVN) was down -1.84% during the last trading session, with a high of 9.44 and the volume of Lifevantage Corporation shares traded was 59730.
LifeVantage Corporation is a science-based network marketing company. The Company focuses on helping people achieve their health, wellness and financial independence goals. The Company provides products and a financially rewarding direct sales business opportunity to customers and independent distributors seeking a healthy lifestyle and financial freedom. It sells its products to preferred customers, retail customers and independent distributors located in the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand and the United Kingdom. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim, its scientifically-validated dietary supplement; LifeVantage TrueScience, its line of anti-aging skin care products; Canine Health; Axio, its energy drink mixes, and PhysIQ.